From high treatment costs to gene therapy breakthroughs, here’s what India’s rare disease framework means for patients and ...

CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...

Purdue Biologist Stanton B. Gelvin explained how Agrobacterium moves DNA into wounded plant cells, and why cracking that “black box” matters for agriculture during a seminar Wednesday afternoon at the ...

Scientists generate world’s first ’extraordinary aromatic tomato plants’ by simultaneously altering two key genes ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.

One of the most promising is its cardiovascular disease therapy candidate CTX310, a single-treatment gene therapy that has been shown to reduce triglycerides and LDL cholesterol by more than 80%.

If you are wondering whether CRISPR Therapeutics at around US$53.52 is offering good value today, you are not alone. The stock often attracts investors who care about price versus potential. The share ...

Researchers used a virus-based CRISPR system to precisely edit the gatekeeper enzyme HMGR in petunias and lettuce, ...

A groundbreaking CRISPR tool could reverse the global antibiotic resistance crisis. Could this be the end of superbugs?

Dr Constantinos Patinios, a researcher at the EMBL Partnership Institute at Vilnius University Life Sciences Center (VU LSC), ...

Scientists have bred cows with 'elite genetics' that could see tastier steaks, burgers and mince on supermarket shelves in the UK in just three years.

Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing ...